跳至主要内容
临床试验/EUCTR2005-004074-24-DE
EUCTR2005-004074-24-DE进行中(未招募)不适用

Effectiveness and safety of pregabalin in patients with epilepsy and anxiety disorder. - N/A

Gesellschaft für Epilepsieforschung e.V.0 个研究点开始时间: 2005年12月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Refractory focal epilepsy
  • Anxiety disorder (control group without anxiety disorder)
  • Adults (=18 years)
  • Antiepileptic comedication, = 2 drugs (active VNS will not be considered an AED)
  • Exclusion of pregnancy, sexual abstinence or reliable method of contraception (in women of childbearing age)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pregnancy or lactation period
  • Known intolerability of pregabalin
  • Alcohol dependency or dependency of illicit drugs within the last 2 years
  • Severe disorder of metabolism, progressive disease, severe renal impairment
  • Abnormality of laboratory results of clinical significance or with clinical symptoms
  • Status epilepticus within the last 6 months
  • Participation in other clinical trials/ drug trials within the last 3 months

研究者

发起方
Gesellschaft für Epilepsieforschung e.V.

相似试验

Effectiveness and safety of pregabalin in patients... | 临床试验